To better understand the clinical significance of PDSS2‐Del2, we performed a BaseScopeTM assay on an HCC tissue microarray and found that positive staining for PDSS2‐Del2 predicted a worse overall survival in patients with HCC (P = 0.02). This evidence concerns the gene PDSS2 and hepatocellular carcinoma.